This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
NEW YORK (Reuters) - Out-of-favor U.S. industrial shares will get a chance to win over investors in the coming days as the companies report quarterly results and address concerns about escalating global trade tensions.
HON GEC MTSI GE HON BOE GNE CSX UTX UAL BA
General Electric (NYSE:GE) has recently become a story of one shoe after another dropping. The bounce that GE stock received after its removal from the Dow Jones Industrial Average appears to have run its course. Now, as the Boston-based conglomerate prepares to announce earnings, unwelcome surprises with GE Capital have come to light. This could explain why GE stock is so low. The earnings report should give more insight on whether GE continues on the road to recovery, or if GE Capital forces more shoes to drop.
GE GEC HON GNE UTX MMM
Pratt & Whitney, a division of United Technologies Corp. (NYSE: UTX), announces that the Pratt & Whitney GTF™ engine will power up to 60 Airbus A220 aircraft ordered under a memorandum of understanding by a start-up airline to be based in the United States. The first aircraft is scheduled to be delivered in 2021.
Pratt & Whitney, a division of United Technologies Corp. (NYSE: UTX), and Air Transat today announced the selection of Pratt & Whitney GTF engines to power 17 firm-order A321neo family aircraft: 2 A321neo and 15 long-range A321LR aircraft, the latest variant of the A321neo. All aircraft will be leased from AerCap. This follows the Air Transat announcements in 2017 and 2018 stating its agreements with AerCap for a long-term leasing arrangement.
Pratt & Whitney, a division of United Technologies Corp. (NYSE: UTX), and Air Lease Corporation (ALC) today announced an order for Pratt & Whitney GTF engines to power a pre-existing order between Airbus and ALC for 26 firm A320neo family aircraft. ALC previously ordered GTF engines to power 30 firm A320neo family aircraft. With today's announcement, ALC will manage a total of 56 GTF-powered A320neo family aircraft.
AL ALLLZ UTX
CNBC's Jim Cramer often says that investors should watch the transportation stocks because they offer valuable insights into a key economic driver: commerce. And last week, things didn't look good.
PEI APA UTX TWLO GM.WS.A GM.WS.B GM.WS.C FHN GM PEI.PRD GM.WSB PEI.PRC PEI.PRB FHN.PRA PEI.PRA
The U.S.-China trade war is top of mind for investors, and after interviewing U.S. National Economic Council chief Larry Kudlow, CNBC's Jim Cramer is worried it could get worse.
General Electric Company (GE - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before the market opens. The company’s Aviation segment is likely to benefit from rising global air travel while Renewable Energy is anticipated to enjoy growth in unit orders. In terms of corporate revenues, GE Aviation is one of the largest business units of the company — accounting for 24.8% of revenues in first-quarter 2018.
HON GEC GE MTSI HON GNE UTX
Honeywell International Inc. (HON - Free Report) is slated to report second-quarter 2018 results on Jul 20, before the market opens. The company pulled off an average positive earnings surprise of 1.49% over the preceding four quarters. Notably, its adjusted earnings of $1.95 per share outpaced the Zacks Consensus Estimate of $1.89 in the last reported quarter. Our proven model shows that Honeywell’s earnings will likely beat estimates in the to-be-reported quarter as well.
HON HON ATKR UTX ETN
General Electric Company (GE - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before market open. The company’s GE Power segment might feel the heat from difficult macroeconomic conditions. In terms of corporate revenues, GE Power is the largest business unit of the company — accounting for 25.2% of revenues in first-quarter 2018. Segment’s Q1 Performance, Estimates GE Power’s performance in first-quarter 2018 was weak on a year-over-year basis, with revenues down 7%, primarily due to the lower demand for turbines.
HON GEC GE MTSI HON GNE UTX
Pratt & Whitney, a division of United Technologies Corp. (NYSE: UTX), today announced that Tianjin Airlines and West Air signed a long-term EngineWise Comprehensive service agreement. The agreement will cover Tianjin Airlines and West Air's fleet of 20 firm Airbus A320neo family aircraft, operated by Tianjin Airlines and West Air and powered by Pratt & Whitney GTF™ engines.
The market didn’t start Tuesday’s action on the best foot. But, some encouraging words from Federal Reserve Chairman Jerome Powell soothed investors’ worries, pushing stocks collectively back into the black by an average of 0.4%. Overstock.com (NASDAQ:OSTK) led the way with its 10%-plus gain, though beyond, noteworthy pacesetters were few and far between.
ABT OSTK NFLX NYTAB UTX ABT LEG
Amazon.com, Visa Inc., Apple Inc., Alibaba Group Holdings, and Microsoft are the largest five individual stock positions.
UNLNF HSB SCGLF LLOBF ABLZF CSCO UBS.PRDCL TCTZF GE COF-P VOD SCGLY PBR DDAIF AAWW 500180 MSFT NTES RIO WST AXP LEN.B COF-D COF-C COF-F HEI RTNTF ACA FAF BIDU HBCYF HCS.PRB ASML UL VOD UN BHPBF LLY GSK 0005 HDB GNE BHP 8035 TV SSYS VRNT AZN VALE3 MS.PRE FCX MS.PRF MS.PRG SIVB MS.PRA TOELY 6506 6503 VSH PEGA TOELF SMG SLB SMSN VECO PFIZER HCS HEI.A MS.PRI CFRUY MS.PRK RJD SCL SLB PFE RJF SMSD JD COF.PRG HD COF.PRH SSNLF SMFG COF.PRP UBS DG HDFCBANK COF.PRC HSBC COF.PRD ABEV SF.PRA COF.PRF SNN LFUS COST COF MRAAY LECO TORO SNY V PEP VODPF MRK MRAAF LLD5 SU LLD7 LLD6 LLD1 DPZ LLD2 INGR RIO BLT ULVR BECN YASKY SAN SAM AMX MS TSM YASKF INFY UTX BABA NVO JNJ LLDTF NVS BHPLF AZPN BAP LEN WMGI CFRHF RTPPF CLGX BOE AAPL INTC BBVA KBH POOL LLOY ITUB CRARF TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD LLPG HSEA HSEB LLPC CRARY 500680 ULSGF SMCAY BCS XOM CTRP COF.WS SEM WMT AMZN TCEHY ASML UNLYF SF BC94 BBD STE BRK.A GOOGL RIO BBL GLE BA EWBC PG NTCT YELP GOOG HRC CHE ASX HSBC.PRA ORCL QRVO PFZ BUD GEC MIELF SFN LYG UMPQ ABB VALE BHP MIELY CVX OCLCF SFB
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to UTX / United Technologies Corp. on message board site Silicon Investor.
|United Technologies (UTX)||United Tex-Sol Mines (ASE:UTX.A)|
|Nutraceutix(nutx .96) inhibits lung cancer! News story|
as of ET